These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20875134)

  • 1. Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.
    van der Pals J; Koul S; Andersson P; Götberg M; Ubachs JF; Kanski M; Arheden H; Olivecrona GK; Larsson B; Erlinge D
    BMC Cardiovasc Disord; 2010 Sep; 10():45. PubMed ID: 20875134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model.
    van der Pals J; Koul S; Götberg MI; Olivecrona GK; Ugander M; Kanski M; Otto A; Götberg M; Arheden H; Erlinge D
    BMC Cardiovasc Disord; 2010 Jan; 10():1. PubMed ID: 20047685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs.
    Arslan F; Houtgraaf JH; Keogh B; Kazemi K; de Jong R; McCormack WJ; O'Neill LA; McGuirk P; Timmers L; Smeets MB; Akeroyd L; Reilly M; Pasterkamp G; de Kleijn DP
    Circ Cardiovasc Interv; 2012 Apr; 5(2):279-87. PubMed ID: 22354933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size.
    Götberg M; Olivecrona GK; Engblom H; Ugander M; van der Pals J; Heiberg E; Arheden H; Erlinge D
    BMC Cardiovasc Disord; 2008 Apr; 8():7. PubMed ID: 18402663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
    Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
    J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size.
    Valls-Lacalle L; Barba I; Miró-Casas E; Ruiz-Meana M; Rodríguez-Sinovas A; García-Dorado D
    Sci Rep; 2018 Feb; 8(1):2442. PubMed ID: 29402957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
    Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
    Schulz R; Rose J; Skyschally A; Heusch G
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction.
    Chan W; Taylor AJ; Ellims AH; Lefkovits L; Wong C; Kingwell BA; Natoli A; Croft KD; Mori T; Kaye DM; Dart AM; Duffy SJ
    Circ Cardiovasc Interv; 2012 Apr; 5(2):270-8. PubMed ID: 22496085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothermia during reperfusion does not reduce myocardial infarct size in pigs.
    Maeng M; Mortensen UM; Kristensen J; Kristiansen SB; Andersen HR
    Basic Res Cardiol; 2006 Jan; 101(1):61-8. PubMed ID: 16177842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury.
    De Hoog VC; Timmers L; Van Duijvenvoorde A; De Jager SC; Van Middelaar BJ; Smeets MB; Woodruff TM; Doevendans PA; Pasterkamp G; Hack CE; De Kleijn DP
    Cardiovasc Res; 2014 Sep; 103(4):521-9. PubMed ID: 24935433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.
    Busk M; Maeng M; Kristensen J; Berg JS; Mortensen UM; Nielsen TT; Nielsen-Kudsk JE
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):335-42. PubMed ID: 17122904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery.
    Ravn HB; Moeldrup U; Brookes CI; Ilkjaer LB; White P; Chew M; Jensen L; Johnsen S; Birk-Soerensen L; Hjortdal VE
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):569-74. PubMed ID: 10073959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Techiryan G; Weil BR; Palka BA; Canty JM
    Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model.
    Sihag S; Haas MS; Kim KM; Guerrero JL; Beaudoin J; Alicot EM; Schuerpf F; Gottschall JD; Puro RJ; Madsen JC; Sachs DH; Newman W; Carroll MC; Allan JS
    Circ Cardiovasc Interv; 2016 Jan; 9(1):e002547. PubMed ID: 26671971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.